IDH2 and glioblastoma: Our nCATS technique also identified mutation variants (locus no.4–5 (Fig. 4))in IDH1 and IDH2. The variants in IDH1 are associated with survival in patients with acute myeloid leukemia [38], but their prognostic value in GBM is not known [39].